These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24255042)

  • 1. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis.
    Acera A; Vecino E; Duran JA
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8285-91. PubMed ID: 24255042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers in the tears of patients with ocular surface disease.
    Acera A; Rocha G; Vecino E; Lema I; Durán JA
    Ophthalmic Res; 2008 Oct; 40(6):315-21. PubMed ID: 18688174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oxidative stress and inflammation in conjunctivochalasis.
    Ward SK; Wakamatsu TH; Dogru M; Ibrahim OM; Kaido M; Ogawa Y; Matsumoto Y; Igarashi A; Ishida R; Shimazaki J; Schnider C; Negishi K; Katakami C; Tsubota K
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1994-2002. PubMed ID: 20019361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha.
    Meller D; Li DQ; Tseng SC
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2922-9. PubMed ID: 10967046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
    Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
    Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tear stability after surgery for conjunctivochalasis.
    Hara S; Kojima T; Ishida R; Goto E; Matsumoto Y; Kaido M; Shimazaki J; Dogru M; Tsubota K
    Optom Vis Sci; 2011 Sep; 88(9):1112-8. PubMed ID: 21705941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
    Afonso AA; Sobrin L; Monroy DC; Selzer M; Lokeshwar B; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2506-12. PubMed ID: 10509643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings.
    Wang Y; Dogru M; Matsumoto Y; Ward SK; Ayako I; Hu Y; Okada N; Ogawa Y; Shimazaki J; Tsubota K
    Am J Ophthalmol; 2007 Dec; 144(6):930-937. PubMed ID: 17916317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts.
    Li DQ; Meller D; Liu Y; Tseng SC
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):404-10. PubMed ID: 10670469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
    Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP-9 and the perioperative management of LASIK surgery.
    Sambursky R; O'Brien TP
    Curr Opin Ophthalmol; 2011 Jul; 22(4):294-303. PubMed ID: 21537181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of conjunctivochalasis on the ocular surface.
    Yokoi N; Komuro A; Nishii M; Inagaki K; Tanioka H; Kawasaki S; Kinoshita S
    Cornea; 2005 Nov; 24(8 Suppl):S24-S31. PubMed ID: 16227820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gelatinase expression in ocular surface disorders.
    Sakimoto T; Shoji J; Kanno H; Sawa M
    Jpn J Ophthalmol; 2004; 48(1):17-22. PubMed ID: 14767645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery of the conjunctiva.
    Yokoi N; Inatomi T; Kinoshita S
    Dev Ophthalmol; 2008; 41():138-158. PubMed ID: 18453766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tear osmolarity in patients with severe cases of conjunctivochalasis.
    Fodor E; Kosina-Hagyó K; Bausz M; Németh J
    Curr Eye Res; 2012 Jan; 37(1):80-4. PubMed ID: 22050557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes.
    Chan TC; Ye C; Chan KP; Chu KO; Jhanji V
    Br J Ophthalmol; 2016 Sep; 100(9):1188-91. PubMed ID: 26682569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.
    Sobrin L; Liu Z; Monroy DC; Solomon A; Selzer MG; Lokeshwar BL; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1703-9. PubMed ID: 10845589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye.
    Sambursky R; Davitt WF; Latkany R; Tauber S; Starr C; Friedberg M; Dirks MS; McDonald M
    JAMA Ophthalmol; 2013 Jan; 131(1):24-8. PubMed ID: 23307206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.